Funding Rounds
EBAMed

EBAMed Series A (2023, $15M)

EBAMed

Non-invasive treatment for heart arrhythmias.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $15.70M

Investors